Benefit-risk balance for marketed drugs: evaluating safety signals

Benefit-risk balance for marketed drugs: evaluating safety signals

Kaydedildi:

Detaylı Bibliyografya
Müşterek Yazar:	Council for International Organizations of Medical Sciences (CIOMS)
Materyal Türü:	Kitap
Dil:	English
Baskı/Yayın Bilgisi:	Geneva Council for International Organizations of Medical Sciences (CIOMS) 1998
Konular:	Drugs Pharmaceutic Preparations Pharmaceutical Products Preparations, Pharmaceutical
Online Erişim:	Visit NHRC Library
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Martindale: the complete drug reference
Yazar:: Parfitt, Kathleen
Baskı/Yayın Bilgisi: (1999)

WHO drug information.
Baskı/Yayın Bilgisi: (2000)

WHO expert committee on specifications for pharmaceutical preparations
Baskı/Yayın Bilgisi: (2006)

International nonproprietary names (INN) for pharmaceutical substances : lists 1-65 of proposed INN and lists 1-31 of recommended INN : cumulative list no. 8 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques : listes 1-65 de DCI proposées et listes 1-31 de DCI recommandées : liste récapitulative no. 8.
Baskı/Yayın Bilgisi: (1992)

WHO expert committee on specifications for pharmaceutical preparations
Baskı/Yayın Bilgisi: (2011)

WHO Expert Committee on Specifications for Pharmaceutical Preparations
Baskı/Yayın Bilgisi: (2012)

USP DI. Approved drug products and legal requirements.
Baskı/Yayın Bilgisi: (1995)

Where there are no pharmacists : a guide to managing medicines for all health workers /
Yazar:: Andersson, Sarah
Baskı/Yayın Bilgisi: (2010)

Managing drug supply : the selection, procurement, distribution, and use of pharmaceuticals. the selection, procurement, distribution, and use of pharmaceuticals.
Baskı/Yayın Bilgisi: (1997)

Pharmacology : a patient-centered nursing process approach /
Yazar:: Kee, Joyce LeFever, ve diğerleri

Drug calculations : ratio and proportion problems for clinical practice /
Yazar:: Seltzer, Meta Brown, ve diğerleri

Effective drug regulation a multicountry study /
Yazar:: Ratanawijitrasin, Sauwakon
Baskı/Yayın Bilgisi: (2002)

WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-eighth meeting report /

Preparation of hazardous waste inventory
Yazar:: DEVS Consult Nepal (P) Ltd.
Baskı/Yayın Bilgisi: (2013)

Client satisfaction and quality of curative services for sick children in Nepal: further analysis of the 2015 Nepal Health Facility Survey: DHS further analysis reports No. 114.
Yazar:: Acharya,Kiran
Baskı/Yayın Bilgisi: (2018)

Regulatory Situation of Herbal Medicines
Baskı/Yayın Bilgisi: (1998)

A text book of pharmacognosy.
Yazar:: Raut, Bechan, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Status of Ayurvedic Medicines Available in the Markets of Nepal
Yazar:: Adhikari, SM, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

The Selection and Use of Essential Medicines Reports of the WHO Expert Committee on the Selection and Use of Essential Medicines and the 3rd WHO Model list of essential medicines for children
Baskı/Yayın Bilgisi: (2012)

AHFS drug information 2000
Yazar:: Snow, Elaine, K
Baskı/Yayın Bilgisi: (2000)

Safety requirements for the first use of new drugs and diagnostic agents in man : a review of safety issues in early clinical trials of drugs.
Baskı/Yayın Bilgisi: (1983)

Final Report on Development of Profile of Toxic Waste Products in Nepal
Yazar:: Nepal Health Research Council (NHRC), ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Serotyping and antibiotic resistance profile of common bacterial isolates causing gastroenteritis.
Yazar:: Yadav, Raju
Baskı/Yayın Bilgisi: (2016)

Ensuring balance in national policies on control substances: Guidelines for availability and accessibility of controlled medicines
Baskı/Yayın Bilgisi: (2011)

Clinical trials: study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines
Yazar:: Brody, Tom
Baskı/Yayın Bilgisi: (2016)

Evaluation of certain veterinary drug residues in food
Baskı/Yayın Bilgisi: (2000)

WHO Expert Committee on biological standardization sixty-fourth meeting report /

Study on the Projection and Management of Health Care Professionals for the Next Ten Years
Yazar:: Aryal, BK, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Impact of educational intervention on knowledge and practice of safety precaution of cytotoxic drugs administration among nurse.
Yazar:: Pande, Sarala
Baskı/Yayın Bilgisi: (2011)

Status of Ayurvedic medicines available in the markets of Nepal
Yazar:: Adhikari, Shyam Mani
Baskı/Yayın Bilgisi: (2008)

Status of Ayurvedic Medicines Available in the Markets of Nepal
Yazar:: Adhikari, Shyam Mani, Dr.
Baskı/Yayın Bilgisi: (2012)

Evaluation of certain veterinary drug residues in food: Forty- second report of the joint FAO/WHO expert committee on food additives
Baskı/Yayın Bilgisi: (1995)

Fundamentals of Clinical Trials /
Yazar:: Friedman, Lawrence M, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Evaluation of certain veterinary drug residues in food : seventy-fifth[75th] report of the Joint FAO/WHO Expert Committee on Food Additives
Baskı/Yayın Bilgisi: (2012)

The use of essential drugs : ninth report of the WHO Expert Committee (including the revised Model list of essential drugs).
Baskı/Yayın Bilgisi: (2000)

Drug policy in the Americas
Yazar:: Smith, Peter H.
Baskı/Yayın Bilgisi: (1992)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
Baskı/Yayın Bilgisi: (2011)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
Baskı/Yayın Bilgisi: (2011)

Iodized salt social marketing campaign (ISMAC): Baseline Study
Yazar:: Poudel, Krishna Prasad
Baskı/Yayın Bilgisi: (2015)

Public Health Care Expenditures in Nepal: Review, Analysis and Assessment
Yazar:: Maskay, NM, ve diğerleri
Baskı/Yayın Bilgisi: (2016)